Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses
Condition(s):Actinic KeratosisLast Updated:September 10, 2018Withdrawn
Hide Studies Not Open or Pending
Condition(s):Actinic KeratosisLast Updated:September 10, 2018Withdrawn
Condition(s):Lymphoma, T-Cell, CutaneousLast Updated:August 13, 2019Unknown status
Condition(s):Renal FailureLast Updated:October 22, 2019Completed
Condition(s):Primary/Relapsed Acute Lymphoblastic Leukemia (ALL) of Childhood, Adolescents and Young AdultsLast Updated:December 4, 2023Completed
Condition(s):Adenocarcinoma of the ProstateLast Updated:October 11, 2018Completed
Condition(s):KeratosisLast Updated:February 19, 2007Completed
Condition(s):Brain Tumor; Glioblastoma; Medulloblastoma; Ependymoma; Anaplastic AstrocytomaLast Updated:December 2, 2017Completed
Condition(s):HSV InfectionLast Updated:January 12, 2024Recruiting
Condition(s):GlioblastomaLast Updated:May 19, 2014Terminated
Condition(s):Newly Diagnosed H3-mutated GliomaLast Updated:March 29, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.